论文部分内容阅读
目的:探究布拉氏酵母菌应用在小儿急性腹泻患者治疗中的临床效果以及对细胞免疫功能产生的影响。方法:将2015年1月~2016年1月期间我院收治的140例小儿急性腹泻患者分为两组:对照组和治疗组,每组70例。对照组给予常规治疗,治疗组给予布拉氏酵母菌治疗。结果:对照组的临床总有效率为78.57%,治疗组患者的临床总有效率为94.29%,治疗组患者的临床疗效明显的比对照组高(P<0.05);治疗组患者的血清CD3、CD4、CD8及CD4/CD8水平明显的比对照组高(P<0.05)。结论:布拉氏酵母菌应用在小儿急性腹泻患者治疗中疗效确切,可显著增强患者细胞免疫功能,对于改善患者症状、提高显效率以及提高生活质量用等方面具有着至关重要的作用,值得临床重视并推广。
Objective: To investigate the clinical effect of Brachyerella spp. In the treatment of children with acute diarrhea and its effect on cellular immune function. Methods: 140 children with acute diarrhea treated in our hospital from January 2015 to January 2016 were divided into two groups: control group and treatment group, 70 cases in each group. The control group was given routine treatment, and the treatment group was treated with Brachyerella. Results: The total effective rate in the control group was 78.57%, the total effective rate in the treatment group was 94.29%, and the clinical efficacy in the treatment group was significantly higher than that in the control group (P <0.05). Serum CD3, CD4, CD8 and CD4 / CD8 levels were significantly higher than the control group (P <0.05). Conclusion: The application of B. Saccharomyces in children with acute diarrhea is effective in treating patients with acute diarrhea, which can significantly enhance cellular immune function and plays an important role in improving the symptoms, improving the efficiency and improving the quality of life. It is worthwhile Clinical attention and promotion.